News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024
News Daily News More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis L.A. McKeown February 12, 2024
News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Opinion Off Script My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration Benoy Shah, MBBS, MD(Res) January 24, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Daily News Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show Michael O'Riordan January 10, 2024
News Opinion Editor's Corner Solutions to TCTMD’s 2023 Cardiology Crossword Challenge Shelley Wood January 08, 2024
News Daily News Reduced EF Evident in Some Elite Endurance Athletes Michael O'Riordan December 21, 2023
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023